Podcasts about prescribing

Prescribing in pregnancy can feel intimidating, especially when a patient casually mentions they're 10 weeks along mid-visit. In this minisode, Kaitlyn and Courtney break down the core principles you need to confidently treat common pregnancy complaints, including first-line options for nausea, reflux, and infections, and which antibiotics are safe and when to avoid certain ones on boards and in practice.         Follow us on Instagram: instagram.com/smnpreviewsofficial

Four years after our original antibiotic myth-busting episode (Ep 60), we're back with Dr Riati Scarborough to talk antibiotic prescribing habits. This time we're joined by fellow stewardship expert Dr Laura Hardefeldt, and this time we're asking the harder question: Have we actually changed?The good news? Some prescribing habits are shifting. We're seeing shorter courses and less ‘just in case antibiotic usage. But let's not pat ourselves on the back too quickly. Because some of our most entrenched habits are still alive and well, like how we treat skin disease, and our ongoing love affair with amoxiclav.This episode is a practical, clinically grounded update on what the evidence says in 2026 - and how to make realistic changes without compromising patient care.We cover:Why skin disease remains the single biggest driver of antimicrobial resistance in small animal practice, and what to do about itAmoxicillin vs amoxiclav: when de-escalation is not just safe, but smarterWhy convenience (you know the brand we're talking about right…) is not a clinical indicationTrimethoprim-sulphonamide and the real story on KCS riskDentals, heart murmurs, and what prophylaxis actually looks like in 2026Simple in-clinic stewardship strategies that genuinely shift prescribing behaviourThis isn't about perfection. It's about progress.If you'd like effective antibiotics to still exist in five to ten years…This episode is essential listening.Find out how we can support you in your vet career at ⁠⁠⁠⁠⁠⁠⁠thevetvault.com⁠⁠⁠⁠⁠⁠⁠.⁠Subscribe to our weekly newsletter⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠here⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠for Hubert's favourite clinical and non-clinical learnings from the week.Grab one last handful of spots in the Maldives for our surf/dive vet conference with ⁠Vets On Tour⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. Tips and Timestamps3:03 Progress in prescribing habits including UTI durations and surgical prophylaxis4:55 Skin disease as the biggest problem area in small animal practice7:01 Topical therapy versus systemic antibiotics for skin conditions9:28 Deep pyoderma and the new consensus statement11:00 Gut bacteria as a source of resistant infections12:41 Rise of MRSP, methicillin-resistant Staphylococcus pseudintermedius14:00 Amoxicillin-clavulanate overuse16:47 Vets on Tour conferences advertisement18:08 Pharmacology refresher on amoxicillin, amoxicillin-clavulanate, and cefovecin19:45 Why cefovecin is classified as high importance, vs the convenience argument for cefovecin in cats22:56 Long-acting amoxicillin injections as an alternative24:00 Getting amoxicillin back on the shelf24:53 Communicating antibiotic choices to clients29:32 Dental antibiotics and debunking the heart murmur myth34:07 Subclinical bacteriuria and stopping cultures in asymptomatic patients38:30 Reassessing the dry eye risk of trimethoprim-sulfonamide41:43 Antimicrobial stewardship trial using colour-coded pharmacy shelves

Natur und Pflanzen werden nicht erst sein Ansätzen wie dem Biophilic Design als Zugänge und Werkzeuge einer gesundheitsfördernden Gestaltung betrachtet. In dieser Folge nähern wir uns dieser Thematik in unterschiedlichen Größenordnungen. Vom kleinen Healing Garden des Pflegeheims, über gesundheitsfördernde Landschaftsgestaltung bis hin zur quartiersübergreifenden Stadtplanung. Wo und wie können wir natürliches Grün (und Blau) effektiv als Gesundheitsressource nutzen und was sind dabei Klischees und Vereinfachte Vorstellungen eines zunehmend stark beforschten Fachgebiets? Nora Huxmann ist Gärtnerin von Herzen und der Pflanze in ihrem Studium der Landschaftsarchitektur in England und Deutschland treu geblieben. Als freiberufliche (Pflanz-)Planerin und in ihrer Tätigkeit in Fortbildung und Beratung hat sie besonders Themen der Anlage, Pflege und Entwicklung städtischen Grüns vertieft und sich mit Themen der Klimaresilientz, Biodiversitätsförderung und Gesundem Grün gewidmet.       Weiterführende Informationen und relevante Links: FREMDE IN DER GARTENSCHÖNHEIT: ZUM DISKURS UM PFLANZENHERKÜNFTE IN DER PFLANZENVERWENDUNGHuxmann, N. J., Bürger, L. & Blickwede, H., 20 April 2025, in: FKW : Zeitschrift für Geschlechterforschung und visuelle Kultur. 2025, 75, S. 37-55 (zum Volltext) Herausforderungen in der Umsetzung naturbasierter Therapien. Natur – Gesundheit – Biodiversität. Huxmann, N.; Hubbertz-Josat, S.; Sappok, H.-U.; Wick, K., in: Stadt und Grün. 2/2024 (zum Volltext) Ökologischer Stadtumbau im regionalen StrukturwandelZöllter, C., Ortlepp, R., Knippschild, R., Salleh, A. F. B. M., Juliane Dziumla, Huxmann, N. & Kretschmer, A., 2 Sept. 2024, in: Transforming cities : urbane Systeme im Wandel : das technisch-wissenschaftliche Fachmagazin. 9, 3, S. 28-33 (zum Volltext) Wohnen in der Gartenschönheit – Narrative vom Wohnen in/mit der Natur im 20. JahrhundertHuxmann, N., 21 Sept. 2018, in: FKW : Zeitschrift für Geschlechterforschung und visuelle Kultur. 2018, 64, S. 077-088, 12 S.(zum Volltext) The garden as setting for horticultural therapyHuxmann, N., Juli 2016, in: Acta horticulturae. 1121, S. 39-46 (zum Volltext) Richard Hansen and modern planting designKörner, S., Bellin-Harder, F. & Huxmann, N., 2 Jan. 2016, in:  Journal of landscape architecture : JoLa . 11, 1, S. 18-29 (zum Volltext) When Green became HealthyHuxmann, N., Aug. 2015, in: Acta horticulturae. 1093, S. 161-167 (zum Volltext-)Version

In this podcast, Julia Hanes, Joel Ewert & Dynai Eilig discuss their paper 'Parasports for cerebral palsy: Thinking and ‘prescribing' beyond the Paralympics'. The paper is available here: https://doi.org/10.1111/dmcn.70115 Follow DMCN on Podbean for more: https://dmcn.podbean.com/ ___ Watch DMCN Podcasts on YouTube: https://bit.ly/2ONCYiC __ DMCN Journal: Developmental Medicine & Child Neurology (DMCN) has defined the field of paediatric neurology and childhood-onset neurodisability for over 60 years. DMCN disseminates the latest clinical research results globally to enhance the care and improve the lives of disabled children and their families. DMCN Journal - https://onlinelibrary.wiley.com/journal/14698749 ___ Find us on Twitter! @mackeithpress - https://twitter.com/mackeithpress

HOUR 2: If we know that certain medications can make you homicidal...why are we still prescribing them? full 2278 Mon, 09 Feb 2026 21:00:00 +0000 2AxO8VdvN1BDuWV8vrbGNygoH1tHo8ij news The Dana & Parks Podcast news HOUR 2: If we know that certain medications can make you homicidal...why are we still prescribing them? You wanted it... Now here it is! Listen to each hour of the Dana & Parks Show whenever and wherever you want! © 2025 Audacy, Inc. News False

In this episode, we explore a critical drug interaction: SSRIs combined with anticoagulants increase major bleeding risk by 35-47%. Should age and sex change our prescribing decisions? We break down the evidence from nearly 100,000 patients and discuss safer antidepressant alternatives for high-risk individuals. Faculty: Paul Zarkowski, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.75 CME: Quick Take Vol. 77 Do SSRIs Increase Major Bleeding Risk with Oral Anticoagulants?

Research Looks into the Unnecessary Prescribing of Antibiotics Among DentistsBy Today's RDH ResearchOriginal article published on Today's RDH: https://www.todaysrdh.com/research-looks-into-the-unnecessary-prescribing-of-antibiotics-among-dentists/Need CE? Start earning CE credits today at ⁠⁠https://rdh.tv/ce⁠⁠ Get daily dental hygiene articles at ⁠⁠https://www.todaysrdh.com⁠⁠ Follow Today's RDH on Facebook: ⁠⁠https://www.facebook.com/TodaysRDH/⁠⁠Follow Kara RDH on Facebook: ⁠⁠https://www.facebook.com/DentalHygieneKaraRDH/⁠⁠Follow Kara RDH on Instagram: ⁠⁠https://www.instagram.com/kara_rdh/⁠

GLP-1 medications have become an important part of adult obesity treatment and are now increasingly relevant in pediatric care. As new approvals emerge and clinical guidance continues to evolve, pediatricians are being asked to consider when, and for whom, these therapies may be appropriate. In this episode, we review the current evidence, discuss clinical considerations and examine the evolving role of GLP-1 medications in child and adolescents. Megan Kelsey, MD, is the medical director of both lifestyle medicine and adolescent bariatric surgery. Jaime Moore, MD, specializes in pediatric nutrition and obesity medicine. Both Drs. Moore and Kelsey are on the faculty here at the University of Colorado School of Medicine. Some highlights from this episode include: How GLP-1s are changing lives for kids with obesity  Learning how they work and are administered  The average effect of these medications  The future of use as access to these medications becomes easier Below are some resources mentioned in this episode: Institute for Healthy Childhood Weight University of Minnesota: Virtual Advanced Therapies for Pediatric Obesity Conference For more information on Children's Colorado, visit: childrenscolorado.org. 

After getting completely hacked and losing our entire social media presence, we're pivoting HARD - and it might be exactly what we needed.In this raw, unfiltered episode, Dr. Matthew Weiner and Zoe break down:- WHY we stopped prescribing the "new" Wegovy pill (spoiler: it's 5 years old and we have data you need to hear)- The GLP-1 medication coming in 2026 that could change everything - Retatrutide clinical trial results revealed- How to get REAL Eli Lilly medication for $150/month (not compounded) through a program most people don't know exists- The AI-powered weight loss app Dr. Weiner is coding himself that does what he does in the office (beta testers wanted!)- Why we're ditching Instagram for Reddit and YouTube - and the surprising reason long-form content beats 30-second clipsPLUS: Real patient stories including a VSG + breast cancer + GLP-1 combination success, the truth about oral vs. injectable semaglutide, home-ground flour health claims investigated, and why that "bulge" when you cough isn't what you think it is.If you're on GLP-1s, considering them, or just tired of BS weight loss advice - this episode cuts through the noise with real data, real experience, and real talk.Like, subscribe, and share with someone who needs to hear this (since we can't share it on Instagram anymore)

Episode Notes In this episode of the DASON Digest podcast, DASON Clinical Pharmacist Liaison, Dr. April Dyer, chats with us about an article in ASHE entitled "Implementation of an interruptive electronic health record alert improves optimal antibiotic prescribing in ambulatory patients with acute bacterial sinusitis: a quasi-experiment." The article can be viewed here: https://pubmed.ncbi.nlm.nih.gov/41607693/ For more information about DASON, please visit: https://dason.medicine.duke.edu/

In an era where “there's an app for that” is increasingly the answer, we turn our attention to what digital transformation really means for medicines. Not just convenience and clicks, but safety, understanding, and how people actually experience care.In this episode, hosted by Jamie Hayes, STC, and Gimmo, we're joined by Rahul Singal, Senior Responsible Officer for the Digital Medicines Programme at NHS England. Rahul offers a clear-eyed view of the digitisation of the medicines pathway — from prescribing and dispensing to how patients interact with their medicines through tools like the NHS App.Together, we explore the promise and the pitfalls of digital pharmacy: innovations in community pharmacy, the realities of electronic health records, and the tensions between national ambition and local delivery. This is a conversation about progress — but also about complexity, equity, and what it really takes to make digital healthcare work in practice.Rahul Singal is the Senior Responsible Officer for the Digital Medicines Programme within the Transformation Directorate at NHS England. He leads work to digitise the medicines pathway across the NHS, including e-prescribing, automation, transfer of medicines information, and prescription ordering via the NHS App. He is also Senior Advisor for digital pharmacy and medicines, and Professional Lead for pharmacy in clinical informatics. He has held senior leadership roles across the NHS, including Chief Pharmacist in a London NHS Trust, and was the first Clinical Fellow to the Chief Pharmaceutical Officer, where he led national work on seven-day pharmacy services. Like Gimmo, he holds a Master's in Leadership (Quality Improvement) from Ashridge Executive Education and is a Generation Q Fellow.For our micro-discussion we discuss the paper “Qualitative evaluation of the implementation and national roll-out of the NHS App in England” which examines how the NHS App was implemented during the pandemic and beyond; https://pubmed.ncbi.nlm.nih.gov/39838384/.As with all of our guests, Rahul shares with us his Memory Evoking Medicine, a career anthem and book that has influenced his life. From Prescription to Ocean — A TEDx Talk by Jamie HayesWe're incredibly proud to share that Aural Apothecary co-host Jamie Hayes has taken to the TEDx stage with a thought-provoking talk:  Prescription to Ocean: The Hidden Impact of Medicineshttps://www.youtube.com/watch?v=swCLNaAG5qYJamie explores a fascinating and urgent question: What happens to our medicines once they leave the prescription pad — and how do they impact the world beyond the patient? It's a journey that connects healthcare, the environment, and our shared responsibility for the future. You'll never think about prescribing (or taking) medicines in quite the same way again.Please take a few minutes to watch, reflect, and share — this is a conversation worth having.Please follow us on LinkedIn!Let us know what you think of the show. https://www.linkedin.com/company/auralapothecary/You can listen to the Aural Apothecary playlist here; https://open.spotify.com/playlist/3OsWj4w8sxsvuwR9zMXgn5?si=tiHXrQI7QsGtSQwPyz1KBg You can view the Aural Apothecary Library here;  https://litalist.com/shelf/view-bookcase?publicId=KN6E3OOur website is https://www.theauralapothecary.com/To get in touch follow us on LinkedIn, Bluesky and X @auralapothecary or email us at auralapothecarypod@gmail.com. Don't forget to rate us and comment wherever you have got this podcast from.

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: UK looks at starting universal T1D screening, Dexcom's CEO mentions a new product, bariatric sugery vs GLP medications, FDA approves update to prescribing info for inhaled insulin, miscroplastic and diabetes link studied, and more! Announcing Community Commericals! Learn how to get your message on the show here. Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Omnipod - Simplify Life All about Dexcom  T1D Screening info All about VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Episode transcription with links: (Stacey Track) Welcome! I'm your host Stacey Simms and this is an In The News episode.. where we bringing you the top diabetes stories and headlines happening now. We are less than one month from our first MNO of 2026. Please join us in Silver Spring MD Feb 20 and 21. It's going to be amazing. We're going to Nashville next March 6-7 and we're going to have a great event a Club 1921 we just added on Thursday March 5th for health care providers and patient leaders. All the info is over at diabetes-connetionss.com events/ Okay.. our top story this week: XX   All UK children could be offered screening for type 1 diabetes using a simple finger-prick blood test, say researchers who have been running a large study. This is the ELSA study - Early Surveillance for Autoimmune diabetes, a first of its kind UK study. They tested blood samples from 17,931 children aged 3-13 for autoantibodies, markers of type 1 diabetes that can appear years before symptoms. Families of children found to have early-stage type 1 diabetes received tailored education and ongoing support to prepare for the eventual onset of type 1 diabetes symptoms and to ensure insulin therapy can begin promptly when needed, reducing the chances of needing emergency treatment. Those with one autoantibody also received ongoing support and monitoring.   Some families were also offered teplizumab, the first ever immunotherapy for type 1 diabetes, which can delay the need for insulin by around three years in people with early-stage type 1 diabetes. The second phase has launched and will expand screening to all children in the UK aged 2-17 years, with a focus on younger children (2-3 years) and older teenagers (14-17 years). The research team aims to recruit 30,000 additional children across these new age groups. ELSA 2 will assess how screening can be scaled across the NHS and evaluate its cost-effectiveness. https://www.birmingham.ac.uk/news/2026/childhood-type-1-diabetes-screening-is-effective-and-could-prevent-thousands-of-emergency-diagnoses XX At the J.P. Morgan Healthcare Conference Dexcom CEO Jake Leach says they're going to launch a new product outside the US. I'll link up that interview, The full quote: "When you look at the outside the U.S., there are a lot of structures that are tiered. Patients have access to different types of products, so we've got a new one that we want to introduce that will add flexibility there. It's based on the G7 platform, just like Dexcom ONE+, but it has a unique experience that's tailored for a subset of users that, today, don't have access to Dexcom." Your guess is as good as mine, but sounds more like a pricing or ordering issue than a new bit of hardware or software. Dexcom will also bring Stelo to some international markets this year. And plans a new mobile app experience for the wearable biosensor meant for people who don't dose insulin. Leach also says G8 will be much smaller and with more capability. but is a few years away. https://www.drugdeliverybusiness.com/dexcom-ceo-jake-leach-2026-roadmap-jpm/ XX A new international consensus statement provides guidance for the use of diabetes technology during pregnancy for women with type 1 diabetes (T1D), type 2 diabetes (T2D), or gestational diabetes (GD).   Organized by the diaTribe Foundation, the document was based on evidence where available, as well as opinion from an international group of experts in endocrinology, diabetes technology, and obstetrics & gynecology, among others.   This is the first set of recommendations specifically addressing the use of diabetes technology in pregnancy – and we'll link it up. https://www.medscape.com/viewarticle/new-consensus-statement-addresses-diabetes-tech-pregnancy-2026a100020d XX Bariatric surgery beats GLP-1s for type 2 diabetes across income levels. This study was published this month, looking at nearly 300 patients are 4 medical centers. Success here is measured by lower blood glucose levels, higher weight loss (28% vs. 10%), less use of diabetes medications, remission of diabetes to the point of no longer needing to inject insulin, and reduced risk factors for cardiovascular disease.     Bariatric surgery was better than medical therapy across all social backgrounds, they found, and not just in areas of higher deprivation. The ancillary study was smaller, and some of the participants randomized in earlier stages crossed over from medical to surgical treatment, and the reverse. The authors acknowledged and accounted for these limitations, along with the rapid development of more powerful obesity drugs not fully captured in the study. This was a long term study – more than 12 years – and by the end of the study more people were choosing GLP1 medications. One dividing line: If someone hopes to lose 100 pounds, that's more likely with surgery than with medications.  "Ultimately, we need large, long-term, well-designed studies to clarify the best strategy for a given patient." https://www.statnews.com/2026/01/19/diabetes-study-bariatric-surgery-better-than-glp-1s/ XX Researchers at the University of California, Riverside have reported for the first time that a father's exposure to microplastics (MPs) can lead to metabolic problems in his children, including diabetes. This is a mouse study, but it looks at a previously unrecognized way in which environmental pollution may influence the health of future generations. MPs are extremely small plastic fragments, measuring less than 5 millimeters, that form as consumer products and industrial materials break down. Metabolic disorders describe a group of conditions that include elevated blood pressure, high blood sugar, and excess body fat, all of which raise the risk of heart disease and diabetes. The team found that female offspring of male mice exposed to MPs were far more prone to metabolic disorders than offspring of unexposed fathers, even though all offspring received the same high fat diet.     The research team hopes the findings will guide future investigation into how MPs and even smaller nanoplastics affect human development.   https://scitechdaily.com/microplastics-can-rewire-sperm-triggering-diabetes-in-the-next-generation/ XX The FDA has finalized four new recalls for certain lots of Abbott's FreeStyle Libre 3 and FreeStyle Libre 3 Plus sensors due to ongoing safety concerns. We told you about this in November when Abbott says some of its continuous glucose monitoring (CGM) sensors were providing incorrect low glucose warnings. Internal testing identified the issue—carbon building up in the sensors during the manufacturing process—and determined that approximately 3 million CGM sensors were affected. The sensors were distributed in the United States, Canada and several European countries.  When Abbott shared that announcement, the FDA was still reviewing the situation. No recalls had yet been finalized. Now, however, the agency has announced four new Class I recalls.   https://cardiovascularbusiness.com/topics/clinical/heart-health/fda-confirms-recalls-abbott-cgm-sensors-new-lawsuit-alleges-company-concealed-information XX   Insulet brings back it's U.S. Pod recycling program, now making it available to all U.S. customers. The Pod recycling program, offered at no cost to customers, enables users to request a recycling kit online. This allows them to return their used Omnipods. Insulet then decontaminates the returned Pods before transporting them to a company specializing in recycling for electronics and medical products. Insulet began recycling pilot programs in Mass and California and are rolling it out nationwide. Insulet also has "Pod takeback" programs outside the U.S. in several international markets. These programs enable customers to request a takeback kit by contacting their local customer support team.   https://www.drugdeliverybusiness.com/insulet-expands-us-pod-recycling-program/ XX Up next a new resource for a population at three times the risk for diabetes, but without a lot of access to health information. I The first diabetes information website primarily in ASL has launched. The site includes GIFs and videos on diabetes management and an ASL glossary of diabetes-related terms. This is from University of Utah Health – Called Deaf Diabetes Can Together. Deaf and hard of hearing people are at three times higher risk for diabetes, but access to health information in ASL is limited. https://healthcare.utah.edu/newsroom/news/2026/01/first-diabetes-information-website-asl-launches XX Novo Nordisk ended all work on cell therapies, including a Type 1 diabetes program, in October – and now has found a buyer. Aspect has acquired rights to the assets and giving Novo an option to reengage for later-stage development and commercialization. Novo is helping bankroll Aspect's development of the assets, investing in the company and providing research funding. The arrangement gives Novo a chance to profit from the programs down the line. Novo is eligible for royalties and milestone payments on future product sales and, having handed the reins to Aspect for now, can expand its role in later-stage development and commercialization. The integration will involve the transfer of capabilities and expertise from Novo sites in Denmark and the U.S. to Aspect's Canadian operations. https://www.fiercebiotech.com/biotech/novo-nordisk-offloads-diabetes-assets-aspect-amid-cell-therapy-retreat XX XX Lucas Escobar has carved a role by proving that healthcare marketing can be culturally resonant, commercially powerful and deeply human. As director and head of U.S. consumer marketing at Insulet, he has redefined how the Omnipod tubeless insulin pump shows up in culture, transforming a medical device into a symbol of identity, inclusion and empowerment.   Under Escobar's leadership, Insulet launched three breakthrough initiatives: Dyasonic: Sound of Strength, a Marvel comic collaboration introducing a superhero who uses Omnipod; The Pod Drop, which turned the sound of a pod change into a celebratory music track; and Omnipod Mango x Pantone, medtech's first color partnership, honoring the vibrancy of the diabetes community. Each blended creativity with purpose while driving results, helping fuel Omnipod's consistent double-digit growth and its position as the most prescribed insulin pump in the U.S.   Living with type 1 diabetes himself, Escobar brings lived experience to his work, using storytelling not just to sell, but to make people feel seen.   Click here to return to the 2026 MM+M 40 Under 40 homepage.   From the January 01, 2026 Issue of MM+M - Medical Marketing and Media https://www.mmm-online.com/40-under-40/40-under-40-lucas-escobar-insulet/ -- FDA approves an update to the prescribing info for Afrezza inhaled insulin. This is a revision to the recommendations for the starting mealtime dosage when patients switch from shots or insulin pumps. This is aimed at healthcare providers - the updated labeling was supported by results from the INHALE-3 trial. The FDA is still considering approval of Afrezza for kids – a decision there expect by summer. https://www.globenewswire.com/news-release/2026/01/26/3225442/29517/en/MannKind-Announces-FDA-Approval-of-Updated-Afrezza-Label-Providing-Starting-Dose-Guidance-when-Switching-from-Multiple-Daily-Injections-MDI-or-Insulin-Pump-Mealtime-Therapy.html   -- UK researchers have developed a calculator to predict whether someone is at risk for type 1 diabetes. They're hoping this helps in screening and in preventing DKA at diagnosis. They used the TEDDY study to create this calculator, which right now is in beta form and only for kids and teens ages 8-18. The current beta form of the calculator asks users to answer questions about four factors necessary to estimate a child's risk of developing type 1 diabetes: age, family history, number of confirmed autoantibodies, and genetic risk score. The calculator has been given regulatory approval as a diagnostic in the U.K., and he's working with a company that's hoping to bring it to the U.S. in the next few months in the form of a home genetic test kit. https://www.healthcentral.com/news/type-1-diabetes/new-calculator-might-help-predict-type-1-diabetes-before-symptoms-appear

Healthcare IT leaders are finding innovative ways to address one of medicine's challenges: the exponential growth of clinical knowledge that physicians must navigate daily. In our recent interview, we hear from Julia Vu, Pharm.D., Vice President, GTM North America at Elsevier and Colin Banas, MD, MHA, Chief Medical Officer at DrFirst about their partnership to integrate AI-powered clinical decision support directly into e-prescribing workflows.Both leaders bring extensive backgrounds in clinical informatics, having worked through the Meaningful Use era and witnessed firsthand the challenges of fragmented systems and information overload. Their collaboration addresses a critical gap: providing physicians with trusted, evidence-based content at the moment they need it, without adding to alert fatigue.Learn more about ELSEVIER: https://www.elsevier.com/Learn more about DrFirst: https://drfirst.com/Healthcare IT Community: https://www.healthcareittoday.com/

One of the most basic pillars of health is good nutrition. A range of eating patterns might all be considered balanced diets, but in general people do better when they eat less processed foods and more whole foods. Vegetables and fruits play a starring role in at least two diets that have been studied extensively, […]

Program notes:0:38 Childhood vaccinations nationally1:30 Across 45 states and DC2:34 Level of vaccine protection3:34 Professional societies stepping in3:51 Skilled nursing facilities 4:51 Estimated operating capacity5:51 Backups into hospitals6:51 Staffing not returned to pre-pandemic levels7:35 Prescribing patterns of CNS active meds in older adults8:36 Several classes of medication examined9:36 Last line medications9:50 Mifepristone regulation historically10:50 Consistent findings on safety11:50 FDA looking at REMS12:50 End

When are antibiotics truly indicated in dentistry? How do you manage the patient who's begging for a prescription? And what impact are we having on the gut every time we prescribe unnecessarily? In this episode, Dr. Jeremy Lenaerts joins Jaz to explore the world of antibiotics in dentistry. Together, they cover when to prescribe, when not to, and why analgesics or local measures are often the better option. They also dive into the bigger picture—antibiotic resistance, gut health, and how to navigate those tricky conversations when patients demand antibiotics for the wrong reasons. https://youtu.be/-Q4hvl-8vpU Watch PDP254 on Youtube Protrusive Dental Pearl? Save time and avoid confusion with a ready-made Antibiotics Cheat Sheet that combines the best guidelines into one resource. It covers: True indications and contraindications Drug interactions First, second, and third-line choices Doses and duration

Welcome to the Plant-Based Canada Podcast! In today's episode, we're joined by Amy Ford to discuss sustainable food systems and planetary health in our hospitals and healthcare settings.Amy Ford is the Director of Planetary Health at Nourish Leadership. She is a self-proclaimed intentional synergy seeker, with a career focused in sustainable in-patient food services. She is energized by bringing mission-aligned groups together to spark change and remove roadblocks, in service of improved planetary health. With a decade of health care food leadership, she is intimately aware of the enabling factors for teams to achieve improved procurement values, community collaboration, waste reduction, and menus that are culturally mindful and low-carbon. Amy lives on land that has long existed in reciprocity with the Anishinaabek, Haudenosaunee and Lūnaapéewak people. She is always ready to create in the kitchen, and believes that good food will usher in wonderful, radical changes to our world.Nourish Leadership's Socials:Website: www.nourishleadership.caLinkedin: https://www.linkedin.com/company/nourishleadership/Instagram: @nourishleadBluesky: @nourishlead.bsky.social‬ Amy Ford's Socials:Linkedin: https://www.linkedin.com/in/amyjoyford/  ‪Plant-Based Canada's Socials:Instagram: @plantbasedcanadaorgFacebook: Plant-Based Canada, https://m.facebook.com/plantbasedcanadaorg/Website: https://www.plantbasedcanada.org/X: @PBC_orgBonus PromotionCheck out University of Guelph's online Plant-Based Nutrition Certificate. Each 4-week course will guide you through essential plant-based topics including nutritional benefits, disease prevention, and environmental impacts. You can also customize your learning with unique courses such as Plant-Based Diets for Athletes and Implementing a Plant-Based Diet at Home. As the first university-level plant-based certificate in Canada, you'll explore current research, learn from leading industry experts, and join a community of like-minded people. Use our exclusive discount code PBC2026 to save 10% on all Plant-Based Nutrition Certificate courses. uoguel.ph/pbn.Thank you for tuning in! Make sure to subscribe to the Plant-Based Canada Podcast so you get notified when new episodes are published. This episode was hosted by Stephanie Nishi RD, PhD.Support the show

RCPsych Books Trainee Editor Dr Ayomipo Amiola is joined by Professor Regi Alexander co-editor of The Frith Prescribing Guidelines for People with Intellectual Disability. The fourth edition is out now. More details on the book and to buy: https://tinyurl.com/ycke269d RCPsych members purchasing via Cambridge are entitled to a discount and can request a copy via the College Library. The book can also be found in other bookshops in-store and online. Disclaimer: RCPsych Books is not responsible for statements made by podcast contributors. Unless so stated, the content of this podcast does not necessarily reflect the views of the Books Editor-in-Chief or the Royal College of Psychiatrists.

Jacob Ward of The Rip Current joins Mikah Sargent on the show this week! Lego unveils its Smart Brick. Jacob kvetches about AI's overwhelming presence at CES. We get some on-site reporting from CES. And Utah becomes the first state to allow artificial intelligence to renew medical prescriptions. Mikah talks about Lego's new Smart Brick technology that allows you to interact and play with your Lego sets more directly. Jacob shares his thoughts about the overall theme of AI that has become front and center at this year's CES event. Stephen Robles of beard.fm joins the show live from CES to talk about what he saw at the event. And Ruth Reader of POLITICO stops by to talk about Utah being the first state to allow artificial intelligence to begin renewing medical prescriptions for patients. Hosts: Mikah Sargent and Jacob Ward Guests: Stephen Robles and Ruth Reader Download or subscribe to Tech News Weekly at https://twit.tv/shows/tech-news-weekly. Join Club TWiT for Ad-Free Podcasts! Support what you love and get ad-free audio and video feeds, a members-only Discord, and exclusive content. Join today: https://twit.tv/clubtwit Sponsors: joindeleteme.com/twit promo code TWIT zscaler.com/security

Jacob Ward of The Rip Current joins Mikah Sargent on the show this week! Lego unveils its Smart Brick. Jacob kvetches about AI's overwhelming presence at CES. We get some on-site reporting from CES. And Utah becomes the first state to allow artificial intelligence to renew medical prescriptions. Mikah talks about Lego's new Smart Brick technology that allows you to interact and play with your Lego sets more directly. Jacob shares his thoughts about the overall theme of AI that has become front and center at this year's CES event. Stephen Robles of beard.fm joins the show live from CES to talk about what he saw at the event. And Ruth Reader of POLITICO stops by to talk about Utah being the first state to allow artificial intelligence to begin renewing medical prescriptions for patients. Hosts: Mikah Sargent and Jacob Ward Guests: Stephen Robles and Ruth Reader Download or subscribe to Tech News Weekly at https://twit.tv/shows/tech-news-weekly. Join Club TWiT for Ad-Free Podcasts! Support what you love and get ad-free audio and video feeds, a members-only Discord, and exclusive content. Join today: https://twit.tv/clubtwit Sponsors: joindeleteme.com/twit promo code TWIT zscaler.com/security

Jacob Ward of The Rip Current joins Mikah Sargent on the show this week! Lego unveils its Smart Brick. Jacob kvetches about AI's overwhelming presence at CES. We get some on-site reporting from CES. And Utah becomes the first state to allow artificial intelligence to renew medical prescriptions. Mikah talks about Lego's new Smart Brick technology that allows you to interact and play with your Lego sets more directly. Jacob shares his thoughts about the overall theme of AI that has become front and center at this year's CES event. Stephen Robles of beard.fm joins the show live from CES to talk about what he saw at the event. And Ruth Reader of POLITICO stops by to talk about Utah being the first state to allow artificial intelligence to begin renewing medical prescriptions for patients. Hosts: Mikah Sargent and Jacob Ward Guests: Stephen Robles and Ruth Reader Download or subscribe to Tech News Weekly at https://twit.tv/shows/tech-news-weekly. Join Club TWiT for Ad-Free Podcasts! Support what you love and get ad-free audio and video feeds, a members-only Discord, and exclusive content. Join today: https://twit.tv/clubtwit Sponsors: joindeleteme.com/twit promo code TWIT zscaler.com/security

Jacob Ward of The Rip Current joins Mikah Sargent on the show this week! Lego unveils its Smart Brick. Jacob kvetches about AI's overwhelming presence at CES. We get some on-site reporting from CES. And Utah becomes the first state to allow artificial intelligence to renew medical prescriptions. Mikah talks about Lego's new Smart Brick technology that allows you to interact and play with your Lego sets more directly. Jacob shares his thoughts about the overall theme of AI that has become front and center at this year's CES event. Stephen Robles of beard.fm joins the show live from CES to talk about what he saw at the event. And Ruth Reader of POLITICO stops by to talk about Utah being the first state to allow artificial intelligence to begin renewing medical prescriptions for patients. Hosts: Mikah Sargent and Jacob Ward Guests: Stephen Robles and Ruth Reader Download or subscribe to Tech News Weekly at https://twit.tv/shows/tech-news-weekly. Join Club TWiT for Ad-Free Podcasts! Support what you love and get ad-free audio and video feeds, a members-only Discord, and exclusive content. Join today: https://twit.tv/clubtwit Sponsors: joindeleteme.com/twit promo code TWIT zscaler.com/security

A highlight from exceptional sessions at the 2025 Midyear Clinical Meeting & Exhibition, this episode explores how pharmacists can bridge gaps in care for patients with opioid use disorder (OUD), highlighting strategies for prescribing and optimizing medications for OUD across primary, ambulatory, and acute care settings. We will discuss real-world examples, emerging practices like microdosing and direct-to-inject techniques, and ways pharmacists can make a tangible difference in improving patient outcomes. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In Episode 2 of Pharmacist-Prescribed, hosts Mary Kucek, PMP, Founder and CEO of OvaryIt, and Devin Bustin, MD, Chief Medical Officer of OvaryIt, dive into the practical realities of implementing pharmacist-led prescribing services in community pharmacy settings. The conversation explores how pharmacies can navigate state-specific prescribing authority, standing orders, collaborative practice agreements, staffing concerns, and day-to-day workflows without disrupting existing operations. Listeners will gain a clear picture of how the PRISM platform supports safe, compliant, and efficient clinical service delivery, from patient intake and documentation to e-prescribing and team-based care. Learn more about PRISM or request a demo at https://www.getprismrx.com  

On this episode of Danatech Talks–a special series from The Huddle– Paola Acevedo, PharmD, CDCES, walks through how to simplify the process of prescribing diabetes technology. Paola discusses common pain points both clients and prescribers may face related to documentation, coverage and affordability, and accessibility. She also shares practical strategies, systems and workflows providers and practices can implement to help navigate through these potential challenges.This episode was supported by educational grant funding from Abbott.Explore the latest in diabetes technology as well as trainings and resources on danatech: danatech l Diabetes Technology Education for Healthcare ProfessionalsExplore danatech's technology affordability tool: Diabetes Technology Affordability OptionsListen to previous episodes of our Danatech Talks diabetes technology series: https://thehuddle.simplecast.com/episodes/basics-diabetes-technology-for-health-care-professionalshttps://thehuddle.simplecast.com/episodes/understanding-cgms-and-interpreting-data-for-beginners  Listen to more episodes of The Huddle at adces.org/perspectives/the-huddle-podcast.Learn more about ADCES and the many benefits of membership at adces.org/join. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

This week, in a special holiday edition of The Dr. Hyman Show, I'm revisiting a powerful conversation with Dr. Aseem Malhotra, a leading cardiologist and advocate for ethical, evidence-based medicine, where we unpacked the uncomfortable truths about cholesterol, statins, and what really drives heart disease. Wishing you a peaceful holiday week. We unpack: • Why LDL cholesterol isn't the whole story when it comes to heart disease • How reducing inflammation and insulin resistance can better protect your heart • What statins can—and can't—do to improve real cardiovascular outcomes • How industry influence shapes the prescriptions patients receive Better heart health starts with better information and real progress begins when we stop treating numbers and start treating what's actually causing disease. Hope you have a peaceful holiday week. I look forward to continuing this journey together in the new year. View Show Notes From This Episode Get Free Weekly Health Tips from Dr. Hyman https://drhyman.com/pages/picks?utm_campaign=shownotes&utm_medium=banner&utm_source=podcast Sign Up for Dr. Hyman's Weekly Longevity Journal https://drhyman.com/pages/longevity?utm_campaign=shownotes&utm_medium=banner&utm_source=podcast Join the 10-Day Detox to Reset Your Health https://drhyman.com/pages/10-day-detox Join the Hyman Hive for Expert Support and Real Results https://drhyman.com/pages/hyman-hive This episode is brought to you by Big Bold Health, Sunlighten, Function Health and Pique. Get 20% off HTB Immune Energy Chews at bigboldhealth.com and use code DRMARK20. Head over to sunlighten.com and save up to $1400 or more this holiday season with code HYMAN. Join today at functionhealth.com/mark and use code MARK2026 to get $50 OFF toward your membership. Receive 20% off FOR LIFE + a free Starter Kit with a rechargeable frother and glass beaker at piquelife com/hym

Send us a textIn this episode of our podcast, we delve into the buzzworthy news that's been making waves in the medical community - British doctors are now prescribing 'poo pills' to patients. This conversation starter has sparked a lot of debate and discussion, and we're here to provide you with the insider scoop on this trending topic. With the current events and information overload, it's hard to keep up with what's really important, but our podcast highlights the most significant stories and provides fresh perspectives on cultural commentary and analysis. Our media insights and news commentary will keep you informed and up-to-date on the latest hot topics, and we'll also be sharing our podcast gems and reviews of the most interesting stories. If you're looking for a weekly roundup of the most viral stories and topic analysis, then you're in the right place. Our audio journalism is all about providing you with the story spotlight and cultural insights you need to stay ahead of the curve. So, tune in to our podcast network for the latest news commentary, and find out why you should know about the 'poo pills' that are being prescribed by British doctors. With new episodes released regularly, you'll never miss out on the fresh takes and news highlights that matter most.If you're listening on Spotify or Youtube. Type in your favorite drink/ entree and dessert. Check out my merch and follow us on social media.Thank you for listening and remember to follow and subscribe and share this with your friends if you had a great time with me. This podcast will drop every Tuesday so tune in next week.And Remember to take a shower and brush your teeth! Instagram: ⁠⁠⁠⁠⁠https://www.instagram.com/itzmrpr3zz/⁠⁠⁠⁠⁠TikTok: ⁠⁠⁠⁠⁠https://www.tiktok.com/@mr_pr3zz?lang=en⁠⁠⁠⁠⁠GRAB SOME MERCH: ⁠⁠⁠⁠⁠https://my-store-cebaed.creator-spring.com/⁠⁠Support the show

Based on a popular well known Christmas carol this episode reminds us about prescribing thoughtfully, recognising key red flags, and keeping often-missed diagnoses like bile acid diarrhoea, coeliac disease and liver disease on the radar. The episode also reinforces the importance of early-life microbiome influences and structured differential diagnosis for abdominal symptoms in primary care. Prescribing and de-prescribing • Taper PPIs rather than stopping abruptly to avoid rebound acid hypersecretion, driven by upregulated gastrin during PPI therapy. • Always link NSAID use and H. pylori status to ulcer risk, and remember: gastric ulcers typically cause pain with meals, duodenal ulcers 2–3 hours after eating. Diagnosis, tests and red flags • Use three coeliac test “groups”: serology (tTG/EMA, with total IgA checked), genetics (HLA‑DQ2/DQ8) and duodenal biopsies; ensure patients eat gluten for at least six weeks pre‑testing and to endoscopy. • Actively screen for GI red flags: dysphagia and weight loss (upper GI), PR bleeding and unexplained iron‑deficiency anaemia (lower GI), and escalate for urgent investigation. Practical tools and endoscopy indications • Use the Bristol Stool Chart (types 1–7) routinely in consultations to standardise conversations about stool form and avoid ambiguous “food analogies.” • Remember the three main indications for endoscopy: diagnostic (e.g. dyspepsia, chronic diarrhoea), surveillance (Barrett's, polyp follow‑up) and therapeutic (RFA/EMR in Barrett's, polyp removal). Conditions to consider and not miss • Keep bile acid diarrhoea prominent in the differential for IBS‑D: up to ~40% of IBS‑D patients may have it, particularly with ileal disease/resection, Crohn's, or post‑cholecystectomy. • Maintain a broad GI bleeding differential beyond cancer (e.g. gastritis, peptic ulcer, Mallory–Weiss tear, haemorrhoids/fissures, liver disease/coagulopathy, IBD, angiodysplasia, diverticular disease). Liver disease, microbiome and early life • Remember major causes of liver failure in primary care: excess alcohol, paracetamol overdose, DILI, autoimmune hepatitis, Wilson's disease, haemochromatosis, viral hepatitis B/C and progressive MASLD. • Support breastfeeding where possible to promote a healthy infant microbiome (HMOs favouring bifidobacteria) and recognise how birth mode and early microbes shape immune development and later allergy/immune risk. Structuring abdominal symptom assessment • For undifferentiated abdominal symptoms, consciously work through a core list: IBS, lactose intolerance, coeliac disease, gastroenteritis, SIBO, IBD, diverticular disease, colorectal cancer, peptic ulcer disease, gallstones/biliary colic, pancreatic insufficiency and medication‑related causes (e.g. metformin, NSAIDs, antibiotics). • Use these categories to guide targeted history, examination, basic tests and thresholds for referral back to gastroenterology or specialist services. Chapters (00:00:04) - The 12 Days of Gutmas(00:01:04) - PPIs(00:02:19) - How to manage gastric and duodenal ulcers on(00:03:40) - Celiac disease tests 6, Interventions(00:05:33) - GI red flags on Christmas Day(00:07:48) - The main indications for endoscopy(00:09:07) - 7 causes of liver failure on Christmas Day(00:10:17) - Healthy gut microbiome 8 days after Christmas(00:12:03) - Bile acid diarrhea(00:13:52) - 10 causes of abnormal gastrointestinal bleeding(00:15:34) - The microbiome of the body(00:17:55) - 12 causes of abdominal dysrhythmia(00:19:59) - 12 Days of Gutmas

Professor Tony Avery,  National Clinical Director for Prescribing for NHS England, discusses safer prescribing of medicines. He highlights the changes he would like to see to enable patients to make genuinely informed decisions, which may also sometimes mean that they decide not to go ahead with a treatment. Tony describes how he believes doctors and patients can work together on initial prescribing decisions,  so that patients can be confident that the benefits of the selected approach outweigh the risks. You can find out more about this podcast on its website and if you would like to support it you can do so via Patreon at or via PayPal. The host of the podcast, Liz Tucker is an award winning medical journalist and former BBC producer and director.  You can follow Liz on X and read further information about the podcast on her Substack newsletter. Medical Evidence Matters with Liz Tucker has been selected by Feedspot as one of the top 15 UK Medical Podcasts https://blog.feedspot.com/uk_medical_podcasts/

Discussion on antibiotic prescribing, including a deeper dive in urgent care and pediatric settingsReview of a new study published in the Annals of Internal Medicine looking at antibiotic, glucocorticoid, and opioid prescribing in urgent cares and opportunities to reduce medication overuseHow CommonSpirit is working with Patient-Centered Outcomes Research Institute (PCORI) to implement evidence-based strategies for improving antibiotic prescribing practicesGuest: Dr. Michael DudasPediatrician, Virginia Mason Franciscan HealthChair, CommonSpirit Health Pediatric Collaborative

Chronic Kidney Disease (CKD) explained, including causes and pathophysiology, as well as symptoms and complications. We also look at diagnosis and treatment options. PDFs available here: https://rhesusmedicine.com/pages/nephrologyConsider subscribing (if you found any of the info useful!): https://www.youtube.com/channel/UCRks8wB6vgz0E7buP0L_5RQ?sub_confirmation=1Patreon: https://www.patreon.com/rhesusmedicineBuy Us A Coffee!: https://www.buymeacoffee.com/rhesusmedicineTimestamps:0:00 What is Chronic Kidney Disease?1:45 Chronic Kidney Disease Symptoms & Complications4:51 Chronic Kidney Disease Causes7:20 Chronic Kidney Disease Pathophysiology 8:14 Chronic Kidney Disease Epidemiology / Risk Factors 8:53 Chronic Kidney Disease Diagnosis10:30 Chronic Kidney Disease Treatment LINK TO SOCIAL MEDIA: https://www.instagram.com/rhesusmedicine/ReferencesNICE Clinical Knowledge Summaries (CKS). Definition of Chronic Kidney Disease. Last revised May 2025. Available at: https://cks.nice.org.uk/topics/chronic-kidney-disease/background-information/definition/ (NICE)StatPearls. Chronic Kidney Disease. In StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025. Last updated July 31 2024. Available at: https://www.ncbi.nlm.nih.gov/books/NBK535404/ (NCBI, PubMed)Wikipedia contributors. Chronic kidney disease. Last updated August 2025. Available at: https://en.wikipedia.org/wiki/Chronic_kidney_disease (Wikipedia)GPCPD (HEIW Wales). Prescribing in Acute Kidney Injury (AKI). Updated 2025. Available at: https://gpcpd.heiw.wales/clinical/acute-kidney-injury-in-primary-care/prescribing-in-aki/Kidney International. Epidemiology of chronic kidney disease: an update 2022. Kidney International Supplements, 2022 Apr;12(1):7–11. Available at: https://www.kidney-international.org/article/S0085-2538(22)00518-X/fulltext (PubMed)Disclaimer: Please remember this podcast and all content from Rhesus Medicine is for educational and entertainment purposes only and is not a guide to diagnose or to treat any form of condition. The content is not to be used to guide clinical practice and is not medical advice. Please consult a healthcare professional for medical advice.

Dr. Samantha Green is currently a family physician at the St. Michael's Hospital Sumac Creek Health Centre in Regent Park and an Assistant Professor at the University of Toronto's Temerty Faculty of Medicine under the Department of Family and Community Medicine. She is also Board Member at the Canadian Association of Physicians for the Environment. Dr. Green completed medical school at the University of Ottawa in 2011 and residency in Family Medicine residency at McMaster University in 2013.We discuss her day-to-day with patients, her work with Canadian Family Physician on prioritizing sustainable primary care, the impact of hospital and food systems on the environment, and her advocacy work around climate and planetary health with the Canadian Association of Physicians for the Environment.ResourcesCanadian Association of Physicians for the Environment Dr. Green's work with Canadian Family Physician:“Sustainable Primary Care Toolkit”“Planetary health lens for primary care”“Reducing the environmental burden of unnecessary investigations”“Climate-conscious inhaler prescribing for family physicians”Bonus PromotionCheck out University of Guelph's online Plant-Based Nutrition Certificate. Each 4-week course will guide you through essential plant-based topics including nutritional benefits, disease prevention, and environmental impacts. You can also customize your learning with unique courses such as Plant-Based Diets for Athletes and Implementing a Plant-Based Diet at Home. As the first university-level plant-based certificate in Canada, you'll explore current research, learn from leading industry experts, and join a community of like-minded people. Use our exclusive discount code PBC2026 to save 10% on all Plant-Based Nutrition Certificate courses. uoguel.ph/pbn.Support the show

National Espresso Day.  Entertainment from 1955.  Prescribing beer for medicianl purposes now illegal, WW2 food rationing ended, Jukebox debuts.  Todays birthdays - Franklin Pierce, Boris Karloff, Betty Everett, Bruce Hornsby, Miley Cyrus.  Larry Hagman died.Intro - God did good - Dianna Corcoran     https://www.diannacorcoran.com/Have another espresso - Shel SilversteinAutumn leaves - Roger WilliamsLove love love = Webb PierceBirthdays - In da club - 50 Cent     https://www.50cent.com/The shoop shoop song (its in his kiss) - Betty EverettJust the way it is - Bruce Hornsby & the RangeParty in the USA - Miley CyrusExit - Two Step - Songwriter Melissa Coston   https://www.reverbnation.com/melissacoston/song/34508022-backwoodscountryundergroundradio.com https://www.coolcasts.cooolmedia.com/show/history-factoids-about-today/

In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about artificial sweeteners' impact on cognitive health, how drug company payments influence prescribing decisions, and the use of graphene technology to accelerate maturation of neurons.

Learn How to Think About & Prescribe Effort as a Coach of CrossFit Athletes.» Samuele Marcora Interview: https://www.zoarfitness.com/podcast/181/» Michael FitzGerald Interview: https://www.zoarfitness.com/podcast/172/» Sam Smith Interview: https://www.zoarfitness.com/podcast/095/» Spiral Out Podcast on Power-Duration: https://open.spotify.com/episode/1VAhgEZfrj4jXsU3KHnRiU?si=mLWL5fJQRGOOHulRqFv4VA» Watch This Episode on YouTube: https://youtu.be/jm4VFZ1EVaE» View All Episodes: https://zoarfitness.com/podcast/» Hire a Coach: https://www.zoarfitness.com/coach/» Shop Programs: https://www.zoarfitness.com/product-category/downloads/» Follow ZOAR Fitness on Instagram: https://www.instagram.com/zoarfitness/Support the show

Mr. Joe discovers a new condition known called anosognosia, which essentially defines as experiencing “lack of insight” or “lack of awareness”, when it comes to one's mental health. Mr. Joe compares anosognosia to denial, and also speaks about self-medicating.

Send us a textS5 E109 - Michelle's Conferences Hot TakesWelcome back to Sleep Takeout! In this episode, Daniel and Michelle reunite in the studio to share their hot takes from recent sleep conferences, travel adventures, and the latest in sleep medicine. From packing hacks and conference culture to the real talk on GLP-1 medications and the future of sleep care, this episode is packed with insights, laughs, and practical tips for clinicians and sleep enthusiasts alike.If you enjoy the show, please like, subscribe, and share with a friend—your support helps us grow and bring you more great content!Timestamps:00:00 - Welcome back! Daniel & Michelle reunite in the studio00:38 - Michelle's whirlwind conference season & travel stories01:32 - Packing hacks: vacu-suck bags, hostels, and travel tips03:14 - Carry-on only: Surviving budget airlines04:54 - Souvenir strategies: Magnets, stickers, and packing light05:13 - Conference culture: Corporate vs. private practice attendees06:26 - GLP-1 medications at sleep conferences: Who's prescribing?07:31 - The panel's take: Prescribing, referrals, and patient care09:06 - Michelle's approach: Risks, benefits, and real-world use10:14 - Insurance, pharma, and the realities of new treatments11:04 - Wrapping up conference season & looking ahead to Podfest11:58 - Podcasting updates: Switching to video, YouTube, and feedback12:44 - Call to action: Share, subscribe, and help us grow!13:26 - Final thoughts & goodbyesThanks for listening to Sleep Takeout! Let us know what you think in the comments, and don't forget to share this episode with someone who could use a little more sleep wisdom. Support the show and become a Sleep Takeout+ Supporter: https://www.buzzsprout.com/1692604/supportSleepTakeout #Podcast #SleepMedicine #GLP1 #ConferenceRecap #TravelHacks #healthcare ✨ Real rest isn't just about falling asleep, it's about feeling at ease again. I'm Dr. Daniel Baughn, sleep psychologist and co-host of Sleep Takeout. I help professionals and high-achievers who seem to have everything together on the outside but can't quite turn off their minds at night.

States With Substantial Increases In Buprenorphine Uptake Did So With Increased Medicaid Prescribing, 2018–24 Health Affairs Multiple federal policy changes since 2018 intended to increase buprenorphine prescribing in response to a persistent treatment gap for opioid use disorder (OUD) in the US. Anticipated national increases did not occur, but highly variable state-level trends provide important insights. This study used IQVIA data to examine all-payer and per payer prescribing across states during the period 2018–24.  Researchers found that highly disparate state-level changes suggest that federal policy impacts were mediated by state-specific factors. Medicaid's key role in driving overall prescribing highlights the public health urgency of maintaining expansions and sustaining enrollment for the single adult population.    Read this issue of the ASAM Weekly Subscribe to the ASAM Weekly Visit ASAM

In this podcast accompanying the November issue of DTB (https://dtb.bmj.com/content/63/11) David Phizackerley (DTB Editor) is joined by Syba Sunny (DTB Clinical Editor). David and Syba discuss the editorial that argues that NHS budgets should not be used to ensure that pharmaceutical companies invest in the UK (https://dtb.bmj.com/content/63/11/162). They talk about a DTB Select article that summarises a systematic review and meta-analysis of trials that assessed patients with a reported penicillin or beta-lactam allergy who underwent direct oral penicillin challenge (https://dtb.bmj.com/content/63/11/163). They finish by discussing the main article that explores the intersection of medication errors, prescribing errors, harms resulting from the use of medicines and some legal consequences (https://dtb.bmj.com/content/63/11/168).   Please subscribe to the DTB podcast to get episodes automatically downloaded to your mobile device and computer. Also, please consider leaving us a review or a comment on the DTB Podcast iTunes podcast page. If you want to contact us please email dtb@bmj.com. Thank you for listening.

One of the most important yet often overlooked concepts in pharmacology is the prescribing cascade. It occurs when a new medication is prescribed to treat a side effect caused by another drug, without realizing that the first medication is the root cause. This leads to a chain reaction of additional prescriptions, unnecessary complexity, and often, new adverse effects. Prescribing cascades can sneak up on even the most careful clinicians. A patient develops a new symptom after starting a medication—perhaps swelling, dizziness, or urinary changes—and instead of identifying the drug as the culprit, another medication is added to manage the symptom. Over time, this cycle contributes to polypharmacy, drug interactions, and reduced quality of life. These cascades are particularly concerning in older adults, where multiple comorbidities and high medication counts make it easy for adverse effects to be misinterpreted as new conditions. But they can occur at any age and in any clinical setting. The key to preventing prescribing cascades is maintaining a critical mindset: Assume any new symptoms could be an adverse effect. Review the timing of medication changes relative to the onset of symptoms. Consider deprescribing or adjusting doses before adding new drugs. Encourage thorough medication reconciliation and communication across providers. Recognizing and interrupting the prescribing cascade is one of the simplest and most impactful ways we can improve medication safety. In this podcast, I share some of my favorite real-world examples that illustrate just how easily these cascades can happen.

Dr. Patricia Hasbach of Northwest Ecotherapy joins Will to explore how clinicians can bring the healing power of nature into their therapeutic work. Drawing from her new book, Prescribing Nature: A Clinician's Guide to Ecotherapy, Patricia shares her journey from traditional therapy settings to incorporating the natural world as an active partner in treatment. She explains the concept of the "ecological self" and how reconnecting clients with nature can reduce anxiety, depression, and stress while deepening connection and meaning. Patricia also offers practical guidance on writing "nature prescriptions," navigating ethical considerations, and developing competence for working outdoors. Through personal stories and research insights, she shows how ecotherapy can transform both therapy and the therapist—helping practitioners step beyond the office and into the living world as part of the healing process. U.S.-based customers can get 20% off and free shipping on Patricia Hasbach's new book when ordering through Norton using this link: https://wwnorton.com/books/9781324053668?promo=WWHITE20 Dr. Hasbach's website is- https://www.northwestecotherapy.com/ This podcast is supported by White Mountain Adventure Institute (wmai.org), offering adventure inspired retreats for men.

The October 2025 launch of a new online platform's healthcare venture marks a significant acceleration in the digital transformation of China's medical sector. This move is emblematic of a powerful, broader trend: the strategic entry of Chinese tech titans like Alibaba and JD, alongside specialized health firms, into the industry. By integrating advanced technologies such as artificial intelligence, streamlined online consultations, and direct hospital services, these players are constructing comprehensive digital health ecosystems. On the show: Steve, Yushan & Yushun

In this episode, Dr. Andy Cutler talks with Dr. Ryan Sultán about the evolving landscape of ADHD—why diagnoses and prescriptions have risen across age groups, what recent prescribing data reveal, and how these trends align with real-world clinical experience. They explore how ADHD medications affect not just symptoms but broader outcomes like school, work, and safety, while also addressing concerns about overdiagnosis, misuse, and disparities in access to care.   Dr. Ryan Sultan is a board-certified adult and child psychiatrist specializing in attention-deficit/hyperactivity disorder (ADHD) and assistant professor at Columbia University Irving Medical Center and the New York State Psychiatric Institute. He is the Medical Director of NYC-based Integrative Psychiatry, where he assesses and treats patients using a combination of psychological, social, environmental, and pharmacological modalities. Integrative Psychiatry also provides ADHD treatment in Miami. As an ADHD psychiatrist, he conducts extensive ADHD research with a focus on using big data to improve ADHD treatment in real world settings, advocating for non-pharmacological interventions such as cognitive behavioral therapy (CBT) for ADHD, coaching, and digital tools as a foundational treatment that precedes or supplements medication. He approaches ADHD treatment with a nuanced understanding of the current misuse and overdiagnosis crisis, and addresses this issue through careful assessment and monitoring.   Andrew J. Cutler, MD, is a distinguished psychiatrist and researcher with extensive experience in clinical trials and psychopharmacology. He currently serves as the Chief Medical Officer of Neuroscience Education Institute and holds the position of Clinical Associate Professor of Psychiatry at SUNY Upstate Medical University in Syracuse, New York.  Never miss an episode!

About this episode: Prescribing medicine to address fever or pain in pregnancy is a delicate task with a need to consider both potential benefits and risks. In this episode: Obstetrician Dr. Angie Jelin shares how she discusses Tylenol use with expectant parents in the context of emerging evidence and recent news from the federal government. Guests: Dr. Angie Jelin is the assistant director of prenatal genetics at the Prenatal Diagnostic Center in the Division of Maternal-Fetal Medicine and an assistant professor in the Johns Hopkins Medicine Department of Gynecology and Obstetrics. Host: Dr. Josh Sharfstein is distinguished professor of the practice in Health Policy and Management, a pediatrician, and former secretary of Maryland's Health Department. Show links and related content: Autism Risk Linked to Fever During Pregnancy—Columbia Mailman School of Public Health Interpreting the Data on Tylenol, Pregnancy, and Autism—Public Health On Call (September 2025) Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

Can and should Dentists carry out home sleep testing? It's actually super easy and I have been doing it for 18 months! What happens after you screen them—do you know what to do next? This episode will teach you! Dr. Jaz Gulati shares his personal journey into incorporating sleep testing in practice—after 1.5 years of doing it, the impact has been nothing short of game-changing. https://youtu.be/H4rTkIuOHWI Watch PDP243 on Youtube Joined by clinical sleep scientist Max Thomas in this jam-packed episode, they deep dive into what it really means to go beyond awareness of sleep-disordered breathing. He breaks down the practical steps for dentists who want to do more than just refer—and start making a difference in their patients' lives. You'll learn how to bridge the gap between theory and action, how to screen effectively, and why you play a pivotal role in the patient's journey to better sleep, more energy, and a healthier life. Protrusive Dental Pearl: If a patient has been seen gasping, choking, or stopping breathing during sleep — that's pathognomonic for sleep-disordered breathing.

Host Bill Reichart sits down with Gerry Langan, a patient living with pulmonary arterial hypertension, and her doctor, Peter Hountras, to unpack the appointment that altered her life. Their frank conversation peels back the curtain on a rare, life‑threatening diagnosis and the bold faith that guided their doctor‑patient bond. Hear the story from both sides of the exam room—it's an unforgettable blend of medical insight, spiritual conviction, and human connection.

Welcome to PsychEd, the psychiatry podcast for medical learners, by medical learners. This short episode covers the basics of electroconvulsive therapy.Hosts: Ravi Bhindi (CC3), Dr. Angad Singh (PGY2)Audio Editing: Dr. Angad Singh (PGY2)Show Notes: Dr. Angad Singh (PGY2)Time Stamps:(0:36) - What is ECT?(2:18) - Indications and efficacy(4:35) - Treatment course(4:32) - Combination treatment(6:33) - Medications to discontinue(8:16) - Contraindications(9:40) - Side effects(11:52) - Procedure(16:03) - SummaryResources:https://www.camh.ca/en/health-info/mental-illness-and-addiction-index/electroconvulsive-therapyhttps://sunnybrook.ca/content/?page=psychiatry-electroconvulsive-therapy-ect-faqReferences:Andrade, C., Arumugham, S. S., & Thirthalli, J. (2016). Adverse Effects of Electroconvulsive Therapy. The Psychiatric clinics of North America, 39(3), 513–530.Brakemeier, E. L., Merkl, A., Wilbertz, G., Quante, A., Regen, F., Bührsch, N., van Hall, F., Kischkel, E., Danker-Hopfe, H., Anghelescu, I., Heuser, I., Kathmann, N., & Bajbouj, M. (2014). Cognitive-behavioral therapy as continuation treatment to sustain response after electroconvulsive therapy in depression: a randomized controlled trial. Biological psychiatry, 76(3), 194–202.Espinoza, R. T., & Kellner, C. H. (2022). Electroconvulsive therapy. New England Journal of Medicine, 386(7), 667-672.Gill, S., Hussain, S., Purushothaman, S., Sarma, S., Weiss, A., Chamoli, S., ... & Loo, C. K. (2023). Prescribing electroconvulsive therapy for depression: Not as simple as it used to be. Australian & New Zealand Journal of Psychiatry, 57(9), 1202-1207.Janjua, A. U., Dhingra, A. L., Greenberg, R., & McDonald, W. M. (2020). The efficacy and safety of concomitant psychotropic medication and electroconvulsive therapy (ECT). CNS Drugs, 34(5), 509-520.Jelovac, A., Kolshus, E., & McLoughlin, D. M. (2013). Relapse following successful electroconvulsive therapy for major depression: a meta-analysis. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 38(12), 2467–2474.Kolshus, E., Jelovac, A., & McLoughlin, D. M. (2017). Bitemporal v. high-dose right unilateral electroconvulsive therapy for depression: a systematic review and meta-analysis of randomized controlled trials. Psychological Medicine, 47(3), 518-530.Lam, R. W., Kennedy, S. H., Adams, C., Bahji, A., Beaulieu, S., Bhat, V., ... & Milev, R. V. (2024). Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults: Réseau canadien pour les traitements de l'humeur et de l'anxiété (CANMAT) 2023: Mise à jour des lignes directrices cliniques pour la prise en charge du trouble dépressif majeur chez les adultes. The Canadian Journal of Psychiatry, 69(9), 641-687.Luchini, F., Medda, P., Mariani, M. G., Mauri, M., Toni, C., & Perugi, G. (2015). Electroconvulsive therapy in catatonic patients: Efficacy and predictors of response. World journal of psychiatry, 5(2), 182–192.Tess, A. V., & Smetana, G. W. (2009). Medical evaluation of patients undergoing electroconvulsive therapy. New England Journal of Medicine, 360(14), 1437-1444.Zolezzi M. (2016). Medication management during electroconvulsant therapy. Neuropsychiatric disease and treatment, 12, 931–939.For more PsychEd, follow us on Instagram (@psyched.podcast),  Facebook (PsychEd Podcast), X (@psychedpodcast), and Bluesky (@psychedpodcast.bsky.social‬). You can email us at psychedpodcast@gmail.com and visit our website at psychedpodcast.org.

Send a text to Melissa and she'll answer it on the next episode. Constitutional prescribing stands as the crown jewel of homeopathic practice – the art of understanding not just what symptoms a person has, but who they truly are at their core. This brief yet illuminating episode pulls back the curtain on this profound healing approach that transforms how we view chronic health issues.Melissa explains that your constitution represents your "factory setting" – the genetic blueprint, personality tendencies, and susceptibilities you were born with. The beauty of constitutional prescribing lies in recognizing how life experiences create layers over this core self. Through a compelling example of a child whose calc carb constitution gains a pulsatilla layer after a frightening separation, we see how trauma literally changes our health patterns, food desires, and emotional responses.What makes this episode particularly valuable is its practical application. Parents struggling to understand their child's behavioral shifts, practitioners hitting walls with chronic cases, and anyone experiencing the frustration of remedies that "stop working" will find clarity in the layered approach. The episode offers a tantalizing glimpse into how constitutional prescribing transforms healing from scattered guessing to systematic confidence.Beyond the mechanics of remedy selection, constitutional prescribing touches on deeper dimensions – how trauma leaves layers in our bodies, how our spiritual walk influences our health, and how physical features like hand-to-palm ratios reveal our core constitutional type. This integration of physical, emotional, and spiritual healing sets constitutional prescribing apart as truly holistic medicine.Ready to master this approach yourself? Melissa invites listeners to join the Inner Healing Circle for access to her comprehensive Constitutional Prescribing Masterclass. With visual aids, layer flow diagrams, morphology guides, and case studies, this course equips you to support yourself and loved ones through every health transition. Because true healing isn't about fixing symptoms – it's about supporting the whole person, layer by layer, back to their authentic self.FIND ME!

Vasu Kakarlapudi helps physicians achieve holistic wellness and financial freedom, investing alongside them through Apta. With surgical precision and 20 plus years of real estate success, he leads by example beyond medicine. Top 3 Value Bombs 1. Wealth is a percentage, not a number. True wealth is how much of your week you spend doing what you love, not your net worth. 2. Real estate is a freedom strategy. Time-starved professionals can use real estate not as a side hustle, but as a methodical path to reclaim time and reduce dependency on traditional income. 3. Avoid rookie mistakes. The biggest pitfalls for high-income professionals investing in real estate? Lack of basic education, fear-based inaction, and trusting unqualified people. Visit Vasu's website to dive into free resources and get on the waitlist for his upcoming book The Surgical Investor - Apta Investment Group Sponsors High Level - The ultimate all-in-one platform for Entrepreneurs, marketers, coaches, and agencies. Learn more at HighLevelFire.com. Airbnb - Your home might be worth more than you think. Find out how much at Airbnb.com/host. ZipRecruiter - Streamline your hiring with ZipRecruiter. See why 4 out of 5 employers who post on ZipRecruiter get a quality candidate within the first day. Just go to ZipRecruiter.com/fire to try it for free.